LABU.US Direxion Daily S&P Biotech Bull 3X Shares
- Total assets
- 540M
- Expense ratio
- 0.91%
- Dividend yield
- 0.38%
- 1-year return
- +61.27%
- Holdings
- 157
- Since
- 2015
Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.
What does LABU.US invest in?
- Mostly Other (76.6%)
- Largest sector: Healthcare (98.4%)
- Largest region: North America (98.7%)
- Top 3 holdings: 1.3% of the fund
Asset allocation
- Other 76.6%
- US stocks 20.2%
- Cash 1.4%
- Non-US stocks 0.7%
Top holdings
- Moderna Inc 0.56%
- TG Therapeutics Inc 0.39%
- Biogen Inc 0.39%
- AbbVie Inc 0.38%
- United Therapeutics Corporation 0.38%
Direxion Daily S&P Biotech Bull 3X Shares performance
Sharpe ratio 0.96- This year
- +37.46%
- 1 year
- +61.27%
- 3 years
- +58.57%
- 5 years
- -28.47%
Volatility 68.7% over 1 year and 76.2% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
LABU.US price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
About Direxion Daily S&P Biotech Bull 3X Shares
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.
Full fund profileDirexion Daily S&P Biotech Bull 3X Shares top holdings
4.0% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Moderna Inc MRNA.US | Healthcare | United States | 0.56% |
| TG Therapeutics Inc TGTX.US | Healthcare | United States | 0.39% |
| Biogen Inc BIIB.US | Healthcare | United States | 0.39% |
| AbbVie Inc ABBV.US | Healthcare | United States | 0.38% |
| United Therapeutics Corporation UTHR.US | Healthcare | United States | 0.38% |
| Regeneron Pharmaceuticals Inc REGN.US | Healthcare | United States | 0.38% |
| Exelixis Inc EXEL.US | Healthcare | United States | 0.38% |
| Oruka Therapeutics, Inc. ORKA.US | Healthcare | United States | 0.38% |
| Spyre Therapeutics Inc. SYRE.US | Healthcare | United States | 0.38% |
| Amgen Inc AMGN.US | Healthcare | United States | 0.37% |
The 10 largest of 157 holdings.
LABU.US sector exposure
- Healthcare98.4%
- Financial Services0.5%
Share of the stocks in the fund.
LABU.US regional exposure
- North America98.7%
- Europe Developed1.7%
- United Kingdom1.5%
- Asia Emerging0.0%
Share of the stocks in the fund.
Company size
Average market cap 8.14B- Big cap2.2%
- Medium cap3.4%
- Small cap9.1%
- Micro cap6.1%
Direxion Daily S&P Biotech Bull 3X Shares fund profile
- Fund name
- Direxion Daily S&P Biotech Bull 3X Shares
- Ticker
- LABU.US
- Exchange
- USA Stocks
- Issuer
- Direxion Funds
- Index tracked
- -
- Category
- Leveraged & Inverse Equity
- Domicile
- United States
- Inception date
- May 28, 2015
- Trading currency
- USD
- Expense ratio
- 0.91%
About Direxion Daily S&P Biotech Bull 3X Shares
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.